EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chad E Miller, MD
Piedmont Healthcare Pulmonary and Critical Care Research
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California San Francisco - Fresno
Fresno, California, United States
- Harbor-Ucla Medical Center
Torrance, California, United States
- Florida Hospital
Orlando, Florida, United States
- Piedmont Healthcare Pulmonary and Critical Care Research
Austell, Georgia, United States
- St. Vincent Medical Group
Indianapolis, Indiana, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- University of New Mexico Health Sciences Center
Albuquerque, New Mexico, United States
- University of Cincinnati Health
Cincinnati, Ohio, United States
- the Ohio State University Wexner Medical Center
Columbus, Ohio, United States
- Integris Baptist Medical Center
Oklahoma City, Oklahoma, United States
- Upmc Presbytarian Hospital
Pittsburgh, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2019
- Primary completion
- 11 May 2022
- Completion
- 11 May 2022
- Last update posted
- 7 Aug 2023
- Registered enrollment
- 36
- Registry id
- NCT03497689
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.